NCT06397924

Edible Insects: Good for the Gut and the Globe

Name: Clinical Trial NCT06397924
Creator: Colorado State University
Keywords: Irritable Bowel Syndrome, Chitin Fiber, dietary supplement, clinical trial, United States of America

Colorado State University·ClinicalTrials.gov·dietary supplementRecruitment Completed

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Irritable Bowel Syndrome
Drug/Device/Intervention: Chitin Fiber
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Colorado State University
Location: Fort Collins, United States of America

Timeline & enrollment

Phase: N/A
Start date: Jul 06, 2023
End date: Aug 31, 2024
Enrollment: 20 participants

Primary outcome

Examine the impact that consuming 4 grams of cricket-derived chitin daily for 30 days has on the gut microbiota, intestinal and systemic markers of inflammation, and symptom severity and quality of life in individuals with IBS.

Summary

Edible insects have been eaten by people throughout human history and are consumed today across the globe. Insects are also currently being incorporated into a number of food products in the United States, Canada, and Europe due to their unique nutritional and sustainability attributes. Insects have been touted as an environmental alternative to conventional meat products, but they are unique in containing dietary fiber. The investigators have recently demonstrated in a population of healthy individuals that two weeks of consuming 25 g/day cricket powder may be associated with prebiotic effects by stimulating the growth of Bifidobacterium in the gut. In addition, participants had reduced inflammatory markers in the blood after the cricket intervention. Crickets and other edible insects contain a unique form of fiber called chitin. They would like to explore whether chitin may be responsible for these previously observed effects and particularly if chitin consumption can mitigate symptoms and inflammation associated with the gastrointestinal disorder Irritable Bowel Syndrome (IBS). This project aims to examine the impact of consuming 4 grams of cricket-derived chitin daily for 30 days on the gut microbiota, intestinal and systemic markers of inflammation, and symptom severity and quality of life in individuals with IBS.

ICD-10 classifications

Irritable bowel syndromeOther and unspecified irritable bowel syndromeIrritable bowel syndrome with mixed bowel habits [IBS-M]Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndrome with predominant diarrhoea [IBS-D]

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06397924
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06397924 through Pure Global AI's free database. This phase not specified trial is sponsored by Colorado State University and is currently Recruitment Completed. The study focuses on Irritable Bowel Syndrome. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.